Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Net Income: 2017-2025

Historic Net Income for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $8.8 million.

  • Puma Biotechnology's Net Income fell 56.47% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 28.66%. This contributed to the annual value of $23.2 million for FY2024, which is 7.47% up from last year.
  • As of Q3 2025, Puma Biotechnology's Net Income stood at $8.8 million, which was up 51.05% from $5.9 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Net Income ranged from a high of $20.3 million in Q3 2024 and a low of -$44.7 million during Q3 2021.
  • For the 3-year period, Puma Biotechnology's Net Income averaged around $5.7 million, with its median value being $5.8 million (2023).
  • Its Net Income has fluctuated over the past 5 years, first surged by 1,710.00% in 2023, then crashed by 443.68% in 2024.
  • Quarterly analysis of 5 years shows Puma Biotechnology's Net Income stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then soared by 318.84% to $12.3 million in 2023, then decreased by 0.31% to $12.2 million in 2024, then tumbled by 56.47% to $8.8 million in 2025.
  • Its Net Income was $8.8 million in Q3 2025, compared to $5.9 million in Q2 2025 and $3.0 million in Q1 2025.